Skip to main content

HUSSMAN STRATEGIC ADVISORS, INC.

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1179475 ELLICOTT CITY, MD

Position in ANIP

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,607,570
-$1,429,680 QoQ
Shares Held
31,500
-40.0% QoQ
Ownership
0.137%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#99
of 303 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

HUSSMAN STRATEGIC ADVISORS, INC. holds $14,720,685 across 7 Drug Manufacturers - Specialty & Generic names. ANIP ranks #2 (17.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ANIP
Ani Pharmaceuticals Inc
This page
31,500 $2,607,570

All Filings in ANIP

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,607,570 31,500
2026-03-31 $4,037,250 52,500
2025-12-31 $2,486,610 31,500
2024-12-31 $1,741,320 31,500
2024-06-30 $2,674,560 42,000
2024-03-31 $2,177,595 31,500
2021-06-30 $1,065,520 30,400
2021-03-31 $1,098,656 30,400
2020-12-31 $882,816 30,400
2020-09-30 $1,001,455 35,500
2020-06-30 $1,148,070 35,500
2020-03-31 $1,446,270 35,500